Genepoint Biological Technology is based in Shanghai, China. It has raised $51M in total funding. Latest round: Series D.
Genepoint Biological Technology funding overview
Genepoint Biological Technology is based in Shanghai, China. Genepoint Biological Technology has raised $51M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series D announced in January 2023. The round record for Genepoint Biological Technology runs through 2023; nothing later has been disclosed. Investors on record include LYFE Capital, Huajin Capital, Guofang Capital, Guosheng Capital, Deyi Capital, Guolian Capital. 6 distinct backers are named across the disclosed rounds.
Frequently asked about Genepoint Biological Technology funding
How much has Genepoint Biological Technology raised?
Genepoint Biological Technology has raised $51M in total disclosed funding across the rounds on record.
Who has invested in Genepoint Biological Technology?
LYFE Capital, Huajin Capital, Guofang Capital, Guosheng Capital, Deyi Capital, Guolian Capital are named among the investors backing Genepoint Biological Technology.
What was the latest Genepoint Biological Technology funding round?
The most recent disclosed round is a Series D, announced in January 2023.
Where is Genepoint Biological Technology based?
Genepoint Biological Technology is based in Shanghai, China.
When did Genepoint Biological Technology last raise?
The last disclosed Genepoint Biological Technology round closed in January 2023 at Series D.
Round data for Genepoint Biological Technology is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Shanghai and backer lists below.
Companies related to Genepoint Biological Technology (31)
